BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 23934204)

  • 1. Group A streptococcal emm type prevalence among symptomatic children in Cape Town and potential vaccine coverage.
    Engel ME; Muhamed B; Whitelaw AC; Musvosvi M; Mayosi BM; Dale JB
    Pediatr Infect Dis J; 2014 Feb; 33(2):208-10. PubMed ID: 23934204
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changing epidemiology of acute rheumatic fever in the United States.
    Lee GM; Wessels MR
    Clin Infect Dis; 2006 Feb; 42(4):448-50. PubMed ID: 16421786
    [No Abstract]   [Full Text] [Related]  

  • 3. Comparative M-protein analysis of Streptococcus pyogenes from pharyngitis and skin infections in New Zealand: Implications for vaccine development.
    Williamson DA; Smeesters PR; Steer AC; Morgan J; Davies M; Carter P; Upton A; Tong SY; Fraser J; Moreland NJ
    BMC Infect Dis; 2016 Oct; 16(1):561. PubMed ID: 27733129
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular Epidemiology of Noninvasive and Invasive Group A Streptococcal Infections in Cape Town.
    Barth DD; Naicker P; Engel K; Muhamed B; Basera W; Mayosi BM; Dale JB; Engel ME
    mSphere; 2019 Oct; 4(5):. PubMed ID: 31666314
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The emm-type diversity does not always reflect the M protein genetic diversity--is there a case for designer vaccine against GAS.
    Smeesters PR; Dramaix M; Van Melderen L
    Vaccine; 2010 Jan; 28(4):883-5. PubMed ID: 19963033
    [No Abstract]   [Full Text] [Related]  

  • 6. Seven-year surveillance of north american pediatric group a streptococcal pharyngitis isolates.
    Shulman ST; Tanz RR; Dale JB; Beall B; Kabat W; Kabat K; Cederlund E; Patel D; Rippe J; Li Z; Sakota V;
    Clin Infect Dis; 2009 Jul; 49(1):78-84. PubMed ID: 19480575
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Group A streptococcal meningitis: emm type distribution and theoretical vaccine coverage in children.
    Tuerlinckx D; Gueulette E; Loens K; Goossens H; Smeesters PR
    Acta Clin Belg; 2016 Jun; 71(3):138-41. PubMed ID: 26319426
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immune response against M protein-conserved region peptides from prevalent group A Streptococcus in a North Indian population.
    Gupta VK; Sekhar S; Dhanda V; Toor D; Kumar R; Chakraborti A
    J Microbiol Immunol Infect; 2016 Jun; 49(3):352-8. PubMed ID: 25087198
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systematic Review and Meta-analysis of the Prevalence of Group A Streptococcal
    Salie T; Engel K; Moloi A; Muhamed B; Dale JB; Engel ME
    mSphere; 2020 Jul; 5(4):. PubMed ID: 32669471
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prospective surveillance of streptococcal sore throat in a tropical country.
    Steer AC; Jenney AW; Kado J; Good MF; Batzloff M; Magor G; Ritika R; Mulholland KE; Carapetis JR
    Pediatr Infect Dis J; 2009 Jun; 28(6):477-82. PubMed ID: 19483515
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Concerns for efficacy of a 30-valent M-protein-based Streptococcus pyogenes vaccine in regions with high rates of rheumatic heart disease.
    Giffard PM; Tong SYC; Holt DC; Ralph AP; Currie BJ
    PLoS Negl Trop Dis; 2019 Jul; 13(7):e0007511. PubMed ID: 31269021
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potential coverage of a multivalent M protein-based group A streptococcal vaccine.
    Dale JB; Penfound TA; Tamboura B; Sow SO; Nataro JP; Tapia M; Kotloff KL
    Vaccine; 2013 Mar; 31(12):1576-81. PubMed ID: 23375817
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Group A streptococcal pharyngitis serotype surveillance in North America, 2000-2002.
    Shulman ST; Tanz RR; Kabat W; Kabat K; Cederlund E; Patel D; Li Z; Sakota V; Dale JB; Beall B;
    Clin Infect Dis; 2004 Aug; 39(3):325-32. PubMed ID: 15306998
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Group A streptococcal strains isolated in Lao People's Democratic Republic from 2004 to 2013.
    Rattanavong S; Dance DA; Davong V; Baker C; Frost H; Phetsouvanh R; Vongsouvath M; Newton PN; Steer AC; Smeesters PR
    Epidemiol Infect; 2016 Jun; 144(8):1770-3. PubMed ID: 26645633
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Streptococcus pyogenes emm-types in northern Spain; population dynamics over a 7-year period.
    Tamayo E; Montes M; García-Arenzana JM; Pérez-Trallero E
    J Infect; 2014 Jan; 68(1):50-7. PubMed ID: 23999149
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Seven-year surveillance of emm types of pediatric Group A streptococcal pharyngitis isolates in Western Greece.
    Syrogiannopoulos GA; Grivea IN; Al-Lahham A; Panagiotou M; Tsantouli AG; Michoula Ralf René Reinert AN; van der Linden M
    PLoS One; 2013; 8(8):e71558. PubMed ID: 23977078
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differences between Belgian and Brazilian group A Streptococcus epidemiologic landscape.
    Smeesters PR; Vergison A; Campos D; de Aguiar E; Miendje Deyi VY; Van Melderen L
    PLoS One; 2006 Dec; 1(1):e10. PubMed ID: 17183632
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular characterisation of group A streptococcus isolates recovered from the north-west of Pretoria, South Africa.
    Khosa XV; Kgasha O; Mabuza H; Moshe M; Engel K; Nchabeleng M
    S Afr Med J; 2021 Apr; 111(5):487-490. PubMed ID: 34852893
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bacteriological and molecular studies of group A streptococcal pharyngitis in a south Indian hospital.
    Sindhulina C; Geethalakshmi S; Thenmozhivalli PR; Jose JM; Brahmadathan KN
    Indian J Med Microbiol; 2008; 26(2):197-8. PubMed ID: 18445967
    [No Abstract]   [Full Text] [Related]  

  • 20. Molecular heterogeneity among north Indian isolates of Group A Streptococcus.
    Sagar V; Bakshi DK; Nandi S; Ganguly NK; Kumar R; Chakraborti A
    Lett Appl Microbiol; 2004; 39(1):84-8. PubMed ID: 15189292
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.